International Clinical Trial: A Phase I, single-center, open-label clinical study on the safety, tolerability, and preliminary efficacy of Mycobacterium tuberculosis antigen (EM) for skin testing in patients with tuberculosis and healthy participants

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118400) titled 'A Phase I, single-center, open-label clinical study on the safety, tolerability, and preliminary efficacy of Mycobacterium tuberculosis antigen (EM) for skin testing in patients with tuberculosis and healthy participants' on Feb. 5.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Wuhan Pulmonary Hospital

Condition: Pulmonary Tuberculosis

Intervention: Medium-Dose Group of Healthy Participants (5U/0.1ml):Intradermally inject 0.1ml of Mycobacterium tuberculosis antigen (EM) into either the left or right arm of the participants High-Dose Group of Healthy Participants(10U...